Auris Medical soared as high as 480% on Tuesday on news that its...

• Auris Medical soared as high as 480% on Tuesday on news that its nasal spray, AM-301, could potentially protect against the coronavirus.
• The clinical stage company tested its spray on human nasal cells in a lab, and found that cells treated with AM-301 right before inoculation of the coronavirus saw effective protection.
• In cells treated with the spray, the amount of coronavirus was 90% lower than control groups 48 hours after infection.
• In cells treated with the spray, the amount of coronavirus was 90% lower than control groups 48 hours after infection.

https://www.*.com/auris-medical-pri...onavirus-nasal-spray-protection-covid-2020-12

Auris Medical soared as high as 480% on Tuesday after it announced lab-test results that show its nasal spray could protect against the coronavirus. Shares of the Bermuda-based clinical stage company are now trading at over $5 per share, after closing at just $1.1 on Monday.

Auris tested its nasal spray, AM-301, on human nasal cells reconstituted in a lab. Auris found that cultures treated with AM-301 right before inoculation with the coronavirus saw effective protection against the virus.

48-hours post-infection, the amount of the virus was 90% lower than those observed in controls. 72 hours post-infection, the virus was 99.2% lower. In saline-treated control cultures, the coronavirus replicated efficiently.